5,871 followers
New Research: Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents https://t.co/JlIwSyair2 #FrontiersIn #Pharmacology
New Research: Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents https://t.co/JlIwSyair2 #FrontiersIn #Pharmacology